SAPIENTIA™ is a genome analytics software from Congenica, enabling healthcare professionals to interrogate the human genome for pathogenic DNA variants likely to be the cause of a patient’s inherited disease. With SAPIENTIA™, clinicians can access all of the information required to make an actionable interpretation of a patient’s genome. This technology, developed from a Wellcome Trust Sanger Institute translational research study, is particularly relevant for rare diseases, 75% of which have a genetic cause that manifests during childhood.
Andrea is Head of Clinical Services at Congenica, a company founded on the world-leading genomic technology pioneered at the Wellcome Trust Sanger Institute and the Department of Health. Andrea has over 20 years’ experience in NHS genetic diagnostic laboratories and heads up a team of clinical scientists at Congenica who are responsible for the interpretation of cases for the UK 100,000 genome Project.